(PFE) has launched a new Phase 1 trial called “A PHASE 1, OPEN-LABEL, FIXED SEQUENCE, 2-PERIOD STUDY…” to track how its experimental drug PF-07799544 moves through and leaves the body in healthy men.
Pfizer (PFE) on Saturday reported detailed results from several mid-stage trials, noting that its obesity therapy, berobenatide (PF’3944), added from its Metsera acquisition last year, could become ...
It is definitely a strong contender.
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Hosted on MSN
Pfizer’s New Phase 1 Study on PF-07832837: A Potential Game-Changer for Atopic Dermatitis
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Good day everyone and welcome to Pfizer Flash Live from ADA, spotlighting berobenatide, an investigational potential first-in-class monthly GLP-1 receptor agonist peptide. Today's event is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results